Cissus quadrangularis extract mitigates diabetic cardiomyopathy by inhibiting RAAS activation, inflammation and oxidative stress

References

• Adeghate, E. and Singh, J., 2014. Structural changes in the myocardium during diabetes-induced cardiomyopathy. Heart failure reviews, 19 (1), 15–23.
   PubMed Web of Science ®Google Scholar
• Al-Rasheed, N.M., et al., 2016. Sitagliptin attenuates cardiomyopathy by modulating the JAK/STAT signaling pathway in experimental diabetic rats. Drug design, development and therapy, 10, 2095–2107.
   PubMed Web of Science ®Google Scholar
• Allcock, D.M. and Sowers, J.R., 2010. Best strategies for hypertension management in type 2 diabetes and obesity. Current diabetes reports, 10 (2), 139–144.
   PubMed Web of Science ®Google Scholar
• Asolkar, L.V. and Chopra, R. N., 1992. Second supplement to glossary of Indian medicinal plants with active principles. Publications & Information Directorate, CSIR, New Delhi, India.
   Google Scholar
• Bando, Y.K. and Murohara, T., 2014. Diabetes-related heart failure. Circulation journal, 78 (3), 576–583.
   PubMedGoogle Scholar
• Borghetti, G., et al., 2018. Diabetic cardiomyopathy: current and future therapies. Beyond glycemic control. Frontiers in physiology, 9, 1514.
   PubMed Web of Science ®Google Scholar
• Boudina, S. and Abel, E.D., 2010. Diabetic cardiomyopathy, causes and effects. Reviews in endocrine & metabolic disorders, 11 (1), 31–39.
   PubMed Web of Science ®Google Scholar
• Bugger, H. and Abel, E.D., 2014. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia, 57 (4), 660–671.
   PubMed Web of Science ®Google Scholar
• Cai, L. and Kang, Y.J., 2001. Oxidative stress and diabetic cardiomyopathy. Cardiovascular toxicology, 1 (3), 181–193.
   PubMedGoogle Scholar
• Cas, A.D., et al., 2013. Diabetes and chronic heart failure: from diabetic cardiomyopathy to therapeutic approach. Endocrine, metabolic & immune disorders-drug targets (Formerly Current drug targets-immune, endocrine & metabolic disorders), 13 (1), 38–50.
   PubMed Web of Science ®Google Scholar
• Chen, S., et al., 2003. Differential activation of NF-κB and AP-1 in increased fibronectin synthesis in target organs of diabetic complications. American journal of physiologyendocrinology and metabolism, 284 (6), E1089–E1097.
   Google Scholar
• Enechi, O.C. and Odonwodo, I., 2003. An assessment of the phytochemical and nutrient composition of the pulverized root of Cissus quadrangularis. Bio-research, 1 (1), 63–68.
   Google Scholar
• Ernande, L. and Derumeaux, G., 2012. Diabetic cardiomyopathy: myth or reality? Archives of cardiovascular diseases, 105 (4), 218–225.
   PubMed Web of Science ®Google Scholar
• Fang, Z.Y., Prins, J.B., and Marwick, T.H., 2004. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocrine reviews, 25 (4), 543–567.
   PubMed Web of Science ®Google Scholar
• Frati, G., et al., 2017. An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy. Cardiovascular research, 113 (4), 378–388.
   PubMed Web of Science ®Google Scholar
• Frieler, R.A., and Mortensen, R.M., 2015. Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling. Circulation, 131 (11), 1019–1030.
   PubMed Web of Science ®Google Scholar
• Gregg, E.W., et al., 2007. Mortality trends in men and women with diabetes, 1971 to 2000. Annals of internal medicine, 147 (3), 149–155.
   PubMed Web of Science ®Google Scholar
• Gupta, A.P., et al., 2019. Pancreastatin inhibitor PSTi8 attenuates hyperinsulinemia induced obesity and inflammation mediated insulin resistance via MAPK/NOX3-JNK pathway. European journal of pharmacology, 864, 172723.
   PubMed Web of Science ®Google Scholar
• Gupta, M., Singh, A., and Joshi, H.C., 2015. Berberis Lycium multipotential medicinal application: an overview. International journal of chemical studies, 3 (4), 10–13.
   Google Scholar
• Hamby, R.I., Zoneraich, S., and Sherman, L., 1974. Diabetic cardiomyopathy. JAMA, 229 (13), 1749–1754.
   PubMed Web of Science ®Google Scholar
• Jia, G., et al., 2015. Endothelial mineralocorticoid receptor deletion prevents diet-induced cardiac diastolic dysfunction in females. Hypertension (Dallas, Tex.: 1979), 66 (6), 1159–1167.
   PubMed Web of Science ®Google Scholar
• Jia, G., DeMarco, V.G., and Sowers, J.R., 2016. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nature reviews. Endocrinology, 12 (3), 144–153.
   PubMed Web of Science ®Google Scholar
• Karadbhajne, S.V., Kumbhare, V., and Bombaywala, M.A., 2014. Application of Cissus quadrangularis Linn. (Hadjor) in nutraceutical food (bakery) products. International journal of ChemTech research, 6 (4), 2263–2270.
   Google Scholar
• Khullar, M., et al., 2010. Oxidative stress: a key contributor to diabetic cardiomyopathy. Canadian journal of physiology and pharmacology, 88 (3), 233–240.
   PubMed Web of Science ®Google Scholar
• Kim, J., Wei, Y., and Sowers, J.R., 2008. Role of mitochondrial dysfunction in insulin resistance. Circulation research, 102 (4), 401–414.
   PubMed Web of Science ®Google Scholar
• Kirkman, M.S., et al., 2012. Diabetes in older adults. Diabetes care, 35 (12), 2650–2664.
   PubMed Web of Science ®Google Scholar
• Kumar, B. T., 2018. Qualitative and quantitative analysis of Cissus quadrangularis using different extracts. IOSR journal of pharmacy and biological sciences, 13, 57–60.
   Google Scholar
• Kumar, M., et al., 2010. Anti-osteoporotic constituents from Indian medicinal plants. Phytomedicine: international journal of phytotherapy and phytopharmacology, 17 (13), 993–999.
   PubMed Web of Science ®Google Scholar
• Kumar, P., et al., 2019. New lignan glycosides from Cissus quadrangularis stems. Natural product research, 33 (2), 233–238.
   PubMed Web of Science ®Google Scholar
• Lakshmanan, D.K., et al., 2020. Cissus quadrangularis (veldt grape) attenuates disease progression and anatomical changes in mono sodium iodoacetate (MIA)-induced knee osteoarthritis in the rat model. Food & function, 11 (9), 7842–7855.
   PubMed Web of Science ®Google Scholar
• Lee, T.-I., et al., 2013. Peroxisome proliferator-activated receptors modulate cardiac dysfunction in diabetic cardiomyopathy. Diabetes research and clinical practice, 100 (3), 330–339.
   Google Scholar
• Lingappan, K., 2018. NF-κB in oxidative stress. Current opinion in toxicology, 7, 81–86.
   PubMedGoogle Scholar
• Mahajan, N. and Dhawan, V., 2013. Receptor for advanced glycation end products (RAGE) in vascular and inflammatory diseases. International journal of cardiology, 168 (3), 1788–1794.
   PubMed Web of Science ®Google Scholar
• Malathi, A.N., 2014. Nutritive value of mangoravalli (Cissus quadrangularis) powder and its value addition. Current trends in technology and science, 3 (2), 223–225.
   Google Scholar
• Mehta, M., Kaur, N., and Bhutani, K.K., 2001. Determination of marker constituents from Cissus quadrangularis Linn. and their quantitation by HPTLC and HPLC. Phytochemical analysis, 12 (2), 91–95.
   PubMed Web of Science ®Google Scholar
• Miller, J.A., et al., 1996. Effect of hyperglycaemia on arterial pressure, plasma renin activity and renal function in early diabetes. Clinical science (London, England: 1979), 90 (3), 189–195.
   PubMed Web of Science ®Google Scholar
• Ohtsu, A., et al., 2017. Advanced glycation end products and lipopolysaccharides stimulate interleukin‑6 secretion via the RAGE/TLR4‑NF‑κB‑ROS pathways and resveratrol attenuates these inflammatory responses in mouse macrophages. Experimental and therapeutic medicine, 14 (5), 4363–4370.
   PubMedGoogle Scholar
• Poornima, I.G., Parikh, P., and Shannon, R.P., 2006. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circulation research, 98 (5), 596–605.
   PubMed Web of Science ®Google Scholar
• Prabhu, S.D. and Frangogiannis, N.G., 2016. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circulation research, 119 (1), 91–112.
   PubMed Web of Science ®Google Scholar
• Prevention, C. and For, D.C. 2011. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 201 (1), 2568–2569.
   Google Scholar
• Ramasamy, R. and Schmidt, A.M., 2012. Receptor for advanced glycation end products (RAGE) and implications for the pathophysiology of heart failure. Current heart failure reports, 9 (2), 107–116.
   PubMedGoogle Scholar
• Rydén, L., et al., 2000. Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial. European heart journal, 21 (23), 1967–1978.
   PubMed Web of Science ®Google Scholar
• Selvin, E., et al., 2010. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. The New England journal of medicine, 362 (9), 800–811.
   PubMed Web of Science ®Google Scholar
• Shabab, S., Gholamnezhad, Z., and Mahmoudabady, M., 2021. Protective effects of medicinal plant against diabetes induced cardiac disorder: a review. Journal of ethnopharmacology, 265, 113328.
   PubMed Web of Science ®Google Scholar
• Shindler, D.M., et al., 1996. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. The American journal of cardiology, 77 (11), 1017–1020.
   PubMed Web of Science ®Google Scholar
• Singh, G., Rawat, P., and Maurya, R., 2007. Constituents of Cissus quadrangularis. Natural product research, 21 (6), 522–528.
   PubMed Web of Science ®Google Scholar
• Singh, N., et al., 2019. Involvement of fatty acid synthase in right ventricle dysfunction in pulmonary hypertension. Experimental cell research, 383 (2), 111569.
   PubMed Web of Science ®Google Scholar
• Suzuki, H., et al., 2015. Arachidonate 12/15-lipoxygenase–induced inflammation and oxidative stress are involved in the development of diabetic cardiomyopathy. Diabetes, 64 (2), 618–630.
   PubMed Web of Science ®Google Scholar
• Syed, A.A., et al., 2016a. Evaluation of anti-hypertensive activity of Ulmus wallichiana extract and fraction in SHR, DOCA-salt-and L-NAME-induced hypertensive rats. Journal of ethnopharmacology, 193, 555–565.
   PubMed Web of Science ®Google Scholar
• Syed, A.A., et al., 2016b. Cardioprotective effect of Ulmus wallichiana planchon in β-adrenergic agonist induced cardiac hypertrophy. Frontiers in pharmacology, 7, 510.
   PubMed Web of Science ®Google Scholar
• Syed, A.A., et al., 2020. Naringin ameliorates type 2 diabetes mellitus-induced steatohepatitis by inhibiting RAGE/NF-κB mediated mitochondrial apoptosis. Life sciences, 257, 118118. https://doi.org/10.1016/j.lfs.2020.118118.
   PubMed Web of Science ®Google Scholar
• Syed, A.A., et al., 2021a. Cissus quadrangularis extract attenuates diabetic nephropathy by altering SIRT1/DNMT1 axis. The journal of pharmacy and pharmacology, 73 (11), 1442–1450.
   PubMed Web of Science ®Google Scholar
• Syed, A.A., et al., 2021b. Inhibition of NOX4 by Cissus quadrangularis extract protects from Type 2 diabetes induced-steatohepatitis. Phytomedicine Plus, 1 (1), 100021. doi:https://doi.org/10.1016/j.phyplu.2021.100021.
   Google Scholar
• Syed, A.A., et al., 2022a. Ethanolic extract of Cissus quadrangularis improves vasoreactivity by modulation of eNOS expression and oxidative stress in spontaneously hypertensive rats. Clinical and experimental hypertension (New York, N.Y.: 1993), 44 (1), 63–71.
   PubMed Web of Science ®Google Scholar
• Syed, A.A., et al., 2022b. Polyphenolic-rich Cissus quadrangularis extract ameliorates insulin resistance by activating AdipoR1 in peri-/post-menopausal rats. Experimental gerontology, 159, 111681.
   PubMed Web of Science ®Google Scholar
• Ti, Y., et al., 2011. TRB3 gene silencing alleviates diabetic cardiomyopathy in a type 2 diabetic rat model. Diabetes, 60 (11), 2963–2974.
   PubMed Web of Science ®Google Scholar
• Wang, Y., et al., 2014. Macrophage mitochondrial oxidative stress promotes atherosclerosis and nuclear factor-κB–mediated inflammation in macrophages. Circulation research, 114 (3), 421–433.
   PubMed Web of Science ®Google Scholar
• Westermeier, F., et al., 2016. New molecular insights of insulin in diabetic cardiomyopathy. Frontiers in physiology, 7, 125.
   PubMed Web of Science ®Google Scholar
• Xu, L., et al., 2016. Inhibition of autophagy increased AGE/ROS-mediated apoptosis in mesangial cells. Cell death & disease, 7 (11), e2445.
   PubMedGoogle Scholar
• Xu, Y.-Z., et al., 2013. An increased circulating angiotensin II concentration is associated with hypoadiponectinemia and postprandial hyperglycemia in men with nonalcoholic fatty liver disease. Internal medicine, 52 (8), 855–861.
   PubMed Web of Science ®Google Scholar
• Yamasaki, Y., et al., 2013. Improved lipid profiles are associated with reduced incidence of coronary vascular events in asymptomatic patients with type 2 diabetes and impaired myocardial perfusion. Journal of atherosclerosis and thrombosis, 20 (4), 13474.
   Web of Science ®Google Scholar